Risk classification for non-cancer death in middle-aged cancer patients

IF 11.4 1区 综合性期刊 Q1 MULTIDISCIPLINARY SCIENCES
Tianwang Guan, Yanting Jiang, Peinan Tu, Baokui Ye, Liangjia Zeng, Zehao Luo, Kaiyi Chi, Haowen Liang, Yuting Yang, Jinqi Huang, Binghua Zhang, Rundong Tai, Jujian Ye, Zhilin Deng, Yushen Ke, Huiwan Chen, Zhiling Zhang, Zhigang Liu, Caiwen Ou
{"title":"Risk classification for non-cancer death in middle-aged cancer patients","authors":"Tianwang Guan, Yanting Jiang, Peinan Tu, Baokui Ye, Liangjia Zeng, Zehao Luo, Kaiyi Chi, Haowen Liang, Yuting Yang, Jinqi Huang, Binghua Zhang, Rundong Tai, Jujian Ye, Zhilin Deng, Yushen Ke, Huiwan Chen, Zhiling Zhang, Zhigang Liu, Caiwen Ou","doi":"10.1016/j.jare.2024.12.039","DOIUrl":null,"url":null,"abstract":"<h3>Introduction</h3>Non-cancer events are important causes of competing mortality among cancer patients. However, the risk of non-cancer death and risk classification in middle-aged cancer patients is not clear. To comprehensively analyze the risk of non-cancer deaths in 24 different cancers among middle-aged patients.<h3>Methods</h3>Standardized mortality rate (SMR), absolute excess risk (AER), proportion of deaths, age-adjusted mortality rate (AAMR), and the competing model were used to assess the risk of non-cancer death in middle-aged cancer patients. A non-cancer death risk classification was developed for the 24 cancer types based on the competing risk of non-cancer death and the risk of non-cancer death (hazard ratio).<h3>Results</h3>A total of 1,082,030 middle-aged cancer patients of 24 cancer types was identified. The risk of non-cancer death was elevated in middle-aged cancer patients compared to the general middle-aged population (SMR = 3.37, 95 % CI 3.35–3.39, AER = 99.18). The cumulative mortality was higher for non-cancer causes compared to primary cancer in 15 cancer types. The AAMR for non-cancer causes declined from 2.3 % in 1975 to 1.4 % in 2017. A risk classification was developed to classify different cancers into 6 risk categories.<h3>Conclusion</h3>The risk of non-cancer death was elevated in middle-aged cancer patients and varied for different cancer types. A new risk classification system was developed to estimate the risk of non-cancer deaths in different cancers, and the 24 cancer types were classified into 6 distinct categories. These results highlight the necessity for risk stratification management for non-cancer death in middle-aged cancer patients.","PeriodicalId":14952,"journal":{"name":"Journal of Advanced Research","volume":"123 1","pages":""},"PeriodicalIF":11.4000,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advanced Research","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1016/j.jare.2024.12.039","RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Non-cancer events are important causes of competing mortality among cancer patients. However, the risk of non-cancer death and risk classification in middle-aged cancer patients is not clear. To comprehensively analyze the risk of non-cancer deaths in 24 different cancers among middle-aged patients.

Methods

Standardized mortality rate (SMR), absolute excess risk (AER), proportion of deaths, age-adjusted mortality rate (AAMR), and the competing model were used to assess the risk of non-cancer death in middle-aged cancer patients. A non-cancer death risk classification was developed for the 24 cancer types based on the competing risk of non-cancer death and the risk of non-cancer death (hazard ratio).

Results

A total of 1,082,030 middle-aged cancer patients of 24 cancer types was identified. The risk of non-cancer death was elevated in middle-aged cancer patients compared to the general middle-aged population (SMR = 3.37, 95 % CI 3.35–3.39, AER = 99.18). The cumulative mortality was higher for non-cancer causes compared to primary cancer in 15 cancer types. The AAMR for non-cancer causes declined from 2.3 % in 1975 to 1.4 % in 2017. A risk classification was developed to classify different cancers into 6 risk categories.

Conclusion

The risk of non-cancer death was elevated in middle-aged cancer patients and varied for different cancer types. A new risk classification system was developed to estimate the risk of non-cancer deaths in different cancers, and the 24 cancer types were classified into 6 distinct categories. These results highlight the necessity for risk stratification management for non-cancer death in middle-aged cancer patients.

Abstract Image

中年癌症患者非癌性死亡的风险分类
非癌症事件是癌症患者竞争死亡率的重要原因。然而,中年癌症患者的非癌性死亡风险及风险分类尚不清楚。综合分析24种不同癌症中年患者的非癌性死亡风险。方法采用标准化死亡率(SMR)、绝对超额风险(AER)、死亡比例、年龄调整死亡率(AAMR)和竞争模型评估中年癌症患者的非癌性死亡风险。根据非癌症死亡的竞争风险和非癌症死亡的风险(风险比),为24种癌症类型制定了非癌症死亡风险分类。结果共检出24种癌症类型的中年癌症患者1,082,030例。与一般中年人群相比,中年癌症患者的非癌性死亡风险升高(SMR = 3.37, 95 % CI 3.35-3.39, AER = 99.18)。在15种癌症类型中,非癌症原因的累积死亡率高于原发性癌症。非癌症原因的AAMR从1975年的2.3 %下降到2017年的1.4 %。一种风险分类将不同的癌症分为6类。结论中年癌症患者的非癌性死亡风险较高,且因癌症类型不同而存在差异。研究人员开发了一种新的风险分类系统,用于估计不同癌症的非癌症死亡风险,并将24种癌症类型分为6个不同的类别。这些结果强调了对中年癌症患者非癌性死亡进行风险分层管理的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Advanced Research
Journal of Advanced Research Multidisciplinary-Multidisciplinary
CiteScore
21.60
自引率
0.90%
发文量
280
审稿时长
12 weeks
期刊介绍: Journal of Advanced Research (J. Adv. Res.) is an applied/natural sciences, peer-reviewed journal that focuses on interdisciplinary research. The journal aims to contribute to applied research and knowledge worldwide through the publication of original and high-quality research articles in the fields of Medicine, Pharmaceutical Sciences, Dentistry, Physical Therapy, Veterinary Medicine, and Basic and Biological Sciences. The following abstracting and indexing services cover the Journal of Advanced Research: PubMed/Medline, Essential Science Indicators, Web of Science, Scopus, PubMed Central, PubMed, Science Citation Index Expanded, Directory of Open Access Journals (DOAJ), and INSPEC.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信